| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | ubiquitin-dependent protein catabolic process via the N-end rule pathway | 4.02e-05 | 4 | 54 | 2 | GO:0071596 | |
| GeneOntologyBiologicalProcess | attachment of GPI anchor to protein | 1.00e-04 | 6 | 54 | 2 | GO:0016255 | |
| GeneOntologyBiologicalProcess | positive regulation of mast cell cytokine production | 1.00e-04 | 6 | 54 | 2 | GO:0032765 | |
| GeneOntologyBiologicalProcess | small intestine smooth muscle contraction | 1.00e-04 | 6 | 54 | 2 | GO:1990770 | |
| GeneOntologyCellularComponent | guanyl-nucleotide exchange factor complex | 3.74e-05 | 24 | 57 | 3 | GO:0032045 | |
| GeneOntologyCellularComponent | C-fiber | 4.37e-05 | 4 | 57 | 2 | GO:0044299 | |
| GeneOntologyCellularComponent | Mon1-Ccz1 complex | 7.27e-05 | 5 | 57 | 2 | GO:0035658 | |
| Domain | ZnF_C2HC | 1.56e-10 | 55 | 52 | 7 | SM00343 | |
| Domain | Znf_CCHC | 1.56e-10 | 55 | 52 | 7 | IPR001878 | |
| Domain | DUF1712 | 7.60e-06 | 2 | 52 | 2 | PF08217 | |
| Domain | DUF1712_fun | 7.60e-06 | 2 | 52 | 2 | IPR013176 | |
| Domain | zf-UBR | 1.58e-04 | 7 | 52 | 2 | PF02207 | |
| Domain | Znf_UBR | 1.58e-04 | 7 | 52 | 2 | IPR003126 | |
| Domain | TLV_coat | 1.58e-04 | 7 | 52 | 2 | PF00429 | |
| Domain | ZnF_UBR1 | 1.58e-04 | 7 | 52 | 2 | SM00396 | |
| Domain | ZF_UBR | 1.58e-04 | 7 | 52 | 2 | PS51157 | |
| Domain | TLV/ENV_coat_polyprotein | 2.11e-04 | 8 | 52 | 2 | IPR018154 | |
| Domain | Na_channel_asu | 3.37e-04 | 10 | 52 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 3.37e-04 | 10 | 52 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 3.37e-04 | 10 | 52 | 2 | PF06512 | |
| Domain | Channel_four-helix_dom | 5.36e-04 | 57 | 52 | 3 | IPR027359 | |
| Domain | - | 5.36e-04 | 57 | 52 | 3 | 1.20.120.350 | |
| Domain | CT | 1.69e-03 | 22 | 52 | 2 | SM00041 | |
| Domain | Cys_knot_C | 2.19e-03 | 25 | 52 | 2 | IPR006207 | |
| Domain | CTCK_2 | 2.19e-03 | 25 | 52 | 2 | PS01225 | |
| Domain | EGF_Ca-bd_CS | 2.50e-03 | 97 | 52 | 3 | IPR018097 | |
| Domain | EGF_CA | 2.64e-03 | 99 | 52 | 3 | PS01187 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.21e-03 | 106 | 52 | 3 | IPR000152 | |
| Domain | Ion_trans_dom | 3.94e-03 | 114 | 52 | 3 | IPR005821 | |
| Domain | Ion_trans | 3.94e-03 | 114 | 52 | 3 | PF00520 | |
| Domain | EGF_3 | 4.12e-03 | 235 | 52 | 4 | PS50026 | |
| Domain | EGF | 4.12e-03 | 235 | 52 | 4 | SM00181 | |
| Domain | EGF_CA | 4.76e-03 | 122 | 52 | 3 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 4.98e-03 | 124 | 52 | 3 | IPR001881 | |
| Domain | LAM_G_DOMAIN | 5.01e-03 | 38 | 52 | 2 | PS50025 | |
| Domain | EGF-like_dom | 5.06e-03 | 249 | 52 | 4 | IPR000742 | |
| Domain | EGF | 5.21e-03 | 126 | 52 | 3 | PF00008 | |
| Domain | EGF_1 | 5.50e-03 | 255 | 52 | 4 | PS00022 | |
| Domain | Laminin_G_2 | 5.54e-03 | 40 | 52 | 2 | PF02210 | |
| Domain | EGF-like_CS | 5.96e-03 | 261 | 52 | 4 | IPR013032 | |
| Domain | EGF_2 | 6.29e-03 | 265 | 52 | 4 | PS01186 | |
| Domain | LamG | 6.67e-03 | 44 | 52 | 2 | SM00282 | |
| Domain | Laminin_G | 1.14e-02 | 58 | 52 | 2 | IPR001791 | |
| Pathway | REACTOME_ATTACHMENT_OF_GPI_ANCHOR_TO_UPAR | 1.11e-04 | 7 | 33 | 2 | M26984 | |
| Pathway | REACTOME_ATTACHMENT_OF_GPI_ANCHOR_TO_UPAR | 1.11e-04 | 7 | 33 | 2 | MM14622 | |
| Pubmed | FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A2P FAM90A1 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 1.52e-30 | 25 | 60 | 13 | 17684299 | |
| Pubmed | FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A2P FAM90A7 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 2.03e-25 | 23 | 60 | 11 | 18602769 | |
| Pubmed | Placental PPARγ regulates spatiotemporally diverse genes and a unique metabolic network. | FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A26 FAM90A23 FAM90A1 FAM90A7 FAM90A9 FAM90A8 FAM90A10 | 5.12e-15 | 164 | 60 | 11 | 22967998 |
| Pubmed | Heat-resistant action potentials require TTX-resistant sodium channels NaV1.8 and NaV1.9. | 2.93e-06 | 2 | 60 | 2 | 29970412 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 18399542 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 24144460 | ||
| Pubmed | Staphylococcus δ-toxin induces allergic skin disease by activating mast cells. | 2.93e-06 | 2 | 60 | 2 | 24172897 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 9891087 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 18826608 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 28450535 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 19931571 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 34930944 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 16857712 | ||
| Pubmed | The Nav1.9 channel is a key determinant of cold pain sensation and cold allodynia. | 2.93e-06 | 2 | 60 | 2 | 25959819 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 31534133 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 23555306 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 30395542 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 32160108 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 38999942 | ||
| Pubmed | Yield of peripheral sodium channels gene screening in pure small fibre neuropathy. | 8.77e-06 | 3 | 60 | 2 | 30554136 | |
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 19638624 | ||
| Pubmed | A family of mammalian E3 ubiquitin ligases that contain the UBR box motif and recognize N-degrons. | 1.75e-05 | 4 | 60 | 2 | 16055722 | |
| Pubmed | The substrate recognition domains of the N-end rule pathway. | 1.75e-05 | 4 | 60 | 2 | 19008229 | |
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 17993265 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 20305638 | ||
| Pubmed | 2.56e-05 | 504 | 60 | 7 | 34432599 | ||
| Pubmed | 2.92e-05 | 5 | 60 | 2 | 25017467 | ||
| Pubmed | Pain-causing stinging nettle toxins target TMEM233 to modulate NaV1.7 function. | 2.92e-05 | 5 | 60 | 2 | 37117223 | |
| Pubmed | 3.07e-05 | 35 | 60 | 3 | 38025786 | ||
| Pubmed | 4.37e-05 | 6 | 60 | 2 | 16029194 | ||
| Pubmed | 4.37e-05 | 6 | 60 | 2 | 23711479 | ||
| Pubmed | 4.37e-05 | 6 | 60 | 2 | 23085571 | ||
| Pubmed | The N-terminal cysteine is a dual sensor of oxygen and oxidative stress. | 6.11e-05 | 7 | 60 | 2 | 34893540 | |
| Pubmed | Pain without nociceptors? Nav1.7-independent pain mechanisms. | 6.11e-05 | 7 | 60 | 2 | 24440715 | |
| Pubmed | 6.11e-05 | 7 | 60 | 2 | 1846368 | ||
| Pubmed | 6.11e-05 | 7 | 60 | 2 | 23575686 | ||
| Pubmed | C. difficile intoxicates neurons and pericytes to drive neurogenic inflammation. | 8.14e-05 | 8 | 60 | 2 | 37699522 | |
| Pubmed | S. aureus drives itch and scratch-induced skin damage through a V8 protease-PAR1 axis. | 8.14e-05 | 8 | 60 | 2 | 37995657 | |
| Pubmed | 8.14e-05 | 8 | 60 | 2 | 33504453 | ||
| Pubmed | 8.14e-05 | 8 | 60 | 2 | 25101983 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 1.00e-04 | 139 | 60 | 4 | 16985003 | |
| Pubmed | 1.05e-04 | 9 | 60 | 2 | 16382098 | ||
| Pubmed | 1.05e-04 | 9 | 60 | 2 | 20362473 | ||
| Pubmed | Human immunodeficiency virus type 1 Vpr links proteasomal degradation and checkpoint activation. | 1.05e-04 | 9 | 60 | 2 | 17855541 | |
| Pubmed | 1.31e-04 | 10 | 60 | 2 | 33098765 | ||
| Pubmed | Molecular cloning of the mouse APS as a member of the Lnk family adaptor proteins. | 1.91e-04 | 12 | 60 | 2 | 10872802 | |
| Pubmed | HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1. | 1.91e-04 | 12 | 60 | 2 | 17360488 | |
| Pubmed | 3.03e-04 | 15 | 60 | 2 | 33722956 | ||
| Pubmed | An enhancer cluster controls gene activity and topology of the SCN5A-SCN10A locus in vivo. | 4.40e-04 | 18 | 60 | 2 | 31666509 | |
| Pubmed | Regulation of developmental lymphangiogenesis by Syk(+) leukocytes. | 4.40e-04 | 18 | 60 | 2 | 20230750 | |
| Pubmed | 4.91e-04 | 19 | 60 | 2 | 24564958 | ||
| Pubmed | 5.28e-04 | 1084 | 60 | 8 | 11544199 | ||
| Pubmed | 6.02e-04 | 21 | 60 | 2 | 25369838 | ||
| Pubmed | 7.23e-04 | 23 | 60 | 2 | 16446141 | ||
| Pubmed | 7.79e-04 | 634 | 60 | 6 | 34591612 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 8.82e-04 | 430 | 60 | 5 | 35044719 | |
| Pubmed | Identification of proteins that interact with alpha A-crystallin using a human proteome microarray. | 1.13e-03 | 118 | 60 | 3 | 24453475 | |
| Pubmed | Atypical E2F repressors and activators coordinate placental development. | 1.49e-03 | 33 | 60 | 2 | 22516201 | |
| Pubmed | 1.49e-03 | 33 | 60 | 2 | 25582440 | ||
| Pubmed | 1.68e-03 | 35 | 60 | 2 | 18498732 | ||
| Interaction | FAM90A26 interactions | 5.10e-06 | 2 | 46 | 2 | int:FAM90A26 | |
| Cytoband | 8p23.1 | FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A2P FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 1.60e-18 | 154 | 60 | 12 | 8p23.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A2P FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 2.61e-16 | 234 | 60 | 12 | chr8p23 |
| Cytoband | 3p22.2 | 4.21e-06 | 24 | 60 | 3 | 3p22.2 | |
| Cytoband | 7p22.1 | 1.75e-03 | 47 | 60 | 2 | 7p22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p22 | 1.83e-03 | 184 | 60 | 3 | chr3p22 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 3.84e-05 | 7 | 25 | 2 | 785 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 6.57e-05 | 9 | 25 | 2 | 1203 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.26e-07 | 161 | 49 | 5 | 176a4a72bb4892932da3c834d1fea5e211847f92 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_1|Classical_Monocyte / Disease condition and Cell class | 1.40e-06 | 175 | 49 | 5 | 35ea2ed93538e6bf803029fcf7d9243f93e7733d | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_1|COVID-19_Severe / Disease condition and Cell class | 1.65e-06 | 181 | 49 | 5 | 0d07a67e8ee3bca687b378afbc4044434e63556d | |
| ToppCell | Ciliated_cells-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 3.33e-05 | 166 | 49 | 4 | 4b1056aad8a99827835242b8ab0c7f2bb84471f1 | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.41e-05 | 167 | 49 | 4 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-conventional_dendritic_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.09e-05 | 175 | 49 | 4 | c58a1f02d1e559d3638fe1500e960e82a8a7187b | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-05 | 178 | 49 | 4 | 579cdc14f28b459e200ae2102e0bd4df8a2c0dcb | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-05 | 178 | 49 | 4 | b1db59344c074c7c80169fc2c5cd5fc89f3fe463 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.86e-05 | 183 | 49 | 4 | 18040d0653286071df959513c63d94b555a5d00a | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.86e-05 | 183 | 49 | 4 | 6ca7c2d7c56e0f1b9038ba677b4c1c3dfd63bfce | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.07e-05 | 185 | 49 | 4 | 53854a9ec87c24c360541c83d86d8fafb303ad58 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.07e-05 | 185 | 49 | 4 | a61fc7a3700a1efcf640bef7680c0443ee148a46 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.07e-05 | 185 | 49 | 4 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Mild-NK|World / Disease group and Cell class | 5.07e-05 | 185 | 49 | 4 | 0565b7c464e1a09e596f5a0b363d2dc9b55c3c50 | |
| ToppCell | P15-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.18e-05 | 186 | 49 | 4 | 521e6e007bbae73e7328153aa170cf04ca3c1093 | |
| ToppCell | P28-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.29e-05 | 187 | 49 | 4 | a4b41904ba05eb76212c949fc3ac197f906c8351 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.51e-05 | 189 | 49 | 4 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.74e-05 | 191 | 49 | 4 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.74e-05 | 191 | 49 | 4 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 192 | 49 | 4 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.22e-05 | 195 | 49 | 4 | 25703e3c2e0512ef12e7aa389fad3968c3f13905 | |
| ToppCell | PBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | 6.35e-05 | 196 | 49 | 4 | 09d197b321ff9f13c0672ea059c850845b0dbbd5 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.47e-05 | 197 | 49 | 4 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.73e-05 | 199 | 49 | 4 | 6aca164bbbb961f34b1e6f1857f91ade5c059405 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.73e-05 | 199 | 49 | 4 | 60919c2af31d39a2d36d7bc432e43dab2a4e05fb | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.86e-05 | 200 | 49 | 4 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.86e-05 | 200 | 49 | 4 | e1dce91c6c531bb212002a14705e496d77ad3490 | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 6.51e-06 | 3 | 44 | 2 | C1833661 | |
| Disease | Primary Erythermalgia | 6.51e-06 | 3 | 44 | 2 | C0014805 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 4.54e-05 | 7 | 44 | 2 | C0020075 | |
| Disease | Congenital Pain Insensitivity | 4.54e-05 | 7 | 44 | 2 | C0002768 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 9.71e-05 | 10 | 44 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 9.71e-05 | 10 | 44 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.42e-04 | 12 | 44 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | male infertility (implicated_via_orthology) | 1.68e-04 | 13 | 44 | 2 | DOID:12336 (implicated_via_orthology) | |
| Disease | Hermansky-Pudlak syndrome (implicated_via_orthology) | 1.96e-04 | 14 | 44 | 2 | DOID:3753 (implicated_via_orthology) | |
| Disease | Chronic myeloproliferative disorder | 3.66e-04 | 19 | 44 | 2 | C1292778 | |
| Disease | interstitial lung disease (is_marker_for) | 6.38e-04 | 25 | 44 | 2 | DOID:3082 (is_marker_for) | |
| Disease | QRS duration | 1.01e-03 | 298 | 44 | 4 | EFO_0005055 | |
| Disease | social communication impairment | 1.05e-03 | 32 | 44 | 2 | EFO_0005427 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AFVGPKLPQVKLFRP | 101 | Q75L30 | |
| QPLPPGFKRFSCLSL | 71 | Q86U02 | |
| LQPLPPGFKQFSCLI | 336 | Q6UX73 | |
| PRPVKQSRKFVPGCF | 361 | Q9H5V8 | |
| GACLFNKPSKLLDPP | 431 | Q9P0K1 | |
| PPGYVFLCGPQKNKL | 251 | B6SEH9 | |
| EKLPPRNTNPGIKCF | 356 | O00213 | |
| APIQACLNFPKKPRL | 296 | A6NDY2 | |
| CLNFPKKPRLGPFQI | 301 | A6NDY2 | |
| QRKLLPFCPPVVLAQ | 701 | Q4ADV7 | |
| APIQACLNFPKKPRL | 296 | A6NKC0 | |
| CLNFPKKPRLGPFQI | 301 | A6NKC0 | |
| TPYGPFPCKAINKIL | 281 | Q15334 | |
| APIQACLNFPKKPRL | 296 | A8MXZ1 | |
| CLNFPKKPRLGPFQI | 301 | A8MXZ1 | |
| NLCRGKNPPPEFAKV | 236 | O60684 | |
| CQGKPLPKDLRFIPD | 151 | P10721 | |
| QFCEVAKGLPLPLPF | 1206 | Q5IJ48 | |
| APIQACLNFPKKPRL | 296 | Q86YD7 | |
| CLNFPKKPRLGPFQI | 301 | Q86YD7 | |
| CLLKKPFNRPQGVQP | 101 | P43405 | |
| PPGYVFLCGPQKNKL | 251 | B6SEH8 | |
| APIQACLNFPKKPRL | 296 | A8MWA6 | |
| CLNFPKKPRLGPFQI | 301 | A8MWA6 | |
| APIQACLNFPKKPRL | 296 | P0C7W9 | |
| CLNFPKKPRLGPFQI | 301 | P0C7W9 | |
| CFPLKIPPNDPRIKN | 291 | P05164 | |
| KQRFLKLLPCCGPQA | 36 | Q9NS61 | |
| FSCPPKFPTQGEKRL | 1386 | P42356 | |
| FGFARLKPPDNQPLK | 566 | O75582 | |
| APIQACLNFPKKPRL | 296 | P0DV74 | |
| CLNFPKKPRLGPFQI | 301 | P0DV74 | |
| APIQACLNFPKKPRL | 296 | P0DV73 | |
| CLNFPKKPRLGPFQI | 301 | P0DV73 | |
| ECPGLDPPFRLKKIQ | 136 | Q9H772 | |
| KRPAQAPIQACLKFP | 291 | P0DV76 | |
| CLKFPKKPRLGPFQI | 301 | P0DV76 | |
| NQRIEFPCPAKGTPK | 1281 | Q96RW7 | |
| APIQACLNFPKKPRL | 296 | A6NJQ4 | |
| CLNFPKKPRLGPFQI | 301 | A6NJQ4 | |
| FLKQFPCPPNSPKAV | 261 | Q3MIT2 | |
| LRRIQPPLGFGKFCP | 1426 | Q13698 | |
| PLNLNDPDAKCRFPK | 286 | P86791 | |
| PLNLNDPDAKCRFPK | 286 | P86790 | |
| GFPNRPKSLKILLNP | 161 | Q49MI3 | |
| QAREKCKPQLLNFPP | 331 | Q99741 | |
| ENCFKPQTIKRPLNP | 206 | Q96HE7 | |
| APIQACLNFPKKPRL | 296 | A6NIJ5 | |
| CLNFPKKPRLGPFQI | 301 | A6NIJ5 | |
| APIQACLNFPKKPRL | 296 | A8MXJ8 | |
| CLNFPKKPRLGPFQI | 301 | A8MXJ8 | |
| PLQFLPLQSGRYPCK | 2281 | Q6ZTR5 | |
| PQPGKLRSPFLQKQL | 276 | Q9UJU6 | |
| APIQACLNFPKKPRL | 296 | P0C7X0 | |
| CLNFPKKPRLGPFQI | 301 | P0C7X0 | |
| LFGIAQPQLPPKCLL | 396 | Q96S52 | |
| LLAPYQACLIPPKKG | 366 | Q7L3T8 | |
| ILPPINRKQCQGPFR | 231 | Q96L03 | |
| KLKSINPPCVPFFGI | 916 | Q07890 | |
| KILNFTGPLFLPPGC | 436 | A2VDJ0 | |
| APIQACLNFPKKPRL | 296 | A8MX19 | |
| CLNFPKKPRLGPFQI | 301 | A8MX19 | |
| APIQACLNFPKKPRL | 296 | A6NNJ1 | |
| CLNFPKKPRLGPFQI | 301 | A6NNJ1 | |
| APIQACLNFPKKPRL | 296 | P0C7W8 | |
| CLNFPKKPRLGPFQI | 301 | P0C7W8 | |
| APIQACLNFPKKPRL | 296 | D6RGX4 | |
| CLNFPKKPRLGPFQI | 301 | D6RGX4 | |
| KLNPDPCKPLAFILI | 846 | Q75T13 | |
| LKNSPFPCNPNKLGV | 41 | Q6P1J6 | |
| APIQACLNFPKKPRL | 296 | P0C7V4 | |
| CLNFPKKPRLGPFQI | 301 | P0C7V4 | |
| FQPIPCKPLFFDLAL | 581 | Q9UHB9 | |
| EFKEFVGLPCKNRPP | 371 | Q96AP0 | |
| GNPRCQKPFFLKEIP | 686 | O75094 | |
| KPKYCLPFLQPGRLV | 646 | P42285 | |
| KPIPRPLNKFQGFVF | 1456 | Q9Y5Y9 | |
| FLIPPSKLCGPFRGQ | 611 | Q7Z404 | |
| RPAQAPIQGCLNFPK | 291 | Q658T7 | |
| PIQGCLNFPKKPRLG | 296 | Q658T7 | |
| LNFPKKPRLGPFQIP | 301 | Q658T7 | |
| LLFCPKQPRLPGQIV | 466 | Q8NDW8 | |
| LCKSFLGENRPPKLP | 126 | Q2VWA4 | |
| KPIPRPLNKCQGLVF | 1346 | Q9UI33 | |
| VPKIYCRGPNPFPQK | 46 | Q8IWV8 | |
| KPKNAFLAPACLPGL | 2636 | Q5T4S7 | |
| KRPAQAPIQACLKFP | 291 | P0DV75 | |
| CLKFPKKPRLGPFQI | 301 | P0DV75 |